nodes	percent_of_prediction	percent_of_DWPC	metapath
Pirenzepine—Azatadine—HRH1—atherosclerosis	0.0422	0.209	CrCbGaD
Pirenzepine—Chlorcyclizine—HRH1—atherosclerosis	0.0416	0.206	CrCbGaD
Pirenzepine—Mirtazapine—HRH1—atherosclerosis	0.0192	0.0952	CrCbGaD
Pirenzepine—Olanzapine—HRH1—atherosclerosis	0.018	0.0894	CrCbGaD
Pirenzepine—Thiothixene—HRH1—atherosclerosis	0.0163	0.0809	CrCbGaD
Pirenzepine—Prochlorperazine—HRH1—atherosclerosis	0.0156	0.0773	CrCbGaD
Pirenzepine—Trifluoperazine—HRH1—atherosclerosis	0.0113	0.0559	CrCbGaD
Pirenzepine—Loxapine—HRH1—atherosclerosis	0.0112	0.0556	CrCbGaD
Pirenzepine—Clozapine—HRH1—atherosclerosis	0.00941	0.0467	CrCbGaD
Pirenzepine—Oxcarbazepine—ALB—atherosclerosis	0.00519	0.0257	CrCbGaD
Pirenzepine—Olanzapine—ALB—atherosclerosis	0.00416	0.0206	CrCbGaD
Pirenzepine—Thioproperazine—ALB—atherosclerosis	0.00383	0.019	CrCbGaD
Pirenzepine—Thiothixene—ALB—atherosclerosis	0.00377	0.0187	CrCbGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.0023	0.00289	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.00229	0.00286	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—CNR2—atherosclerosis	0.00226	0.00283	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.00225	0.00281	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—atherosclerosis	0.00224	0.00281	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—PRKCG—atherosclerosis	0.00223	0.0028	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—HRH1—atherosclerosis	0.00222	0.00278	CbGpPWpGaD
Pirenzepine—CHRM1—Regulation of Actin Cytoskeleton—PIK3CG—atherosclerosis	0.00221	0.00277	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—KNG1—atherosclerosis	0.00213	0.00267	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—AGTR1—atherosclerosis	0.00212	0.00265	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—AGT—atherosclerosis	0.00208	0.00261	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—CCL4—atherosclerosis	0.00207	0.00259	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—UTS2—atherosclerosis	0.00203	0.00255	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—PPARA—atherosclerosis	0.00203	0.00254	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—HRH1—atherosclerosis	0.00202	0.00253	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.00197	0.00247	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.00196	0.00245	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.00196	0.00245	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—CASR—atherosclerosis	0.00195	0.00244	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—CCL3—atherosclerosis	0.00194	0.00243	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—LEP—atherosclerosis	0.00193	0.00241	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—F2—atherosclerosis	0.00192	0.00241	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—atherosclerosis	0.00186	0.00233	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—UTS2—atherosclerosis	0.00184	0.00231	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—CNR2—atherosclerosis	0.00181	0.00227	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.00181	0.00227	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—EDN1—atherosclerosis	0.0018	0.00225	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—NOS2—atherosclerosis	0.00179	0.00225	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—CCL5—atherosclerosis	0.00178	0.00223	CbGpPWpGaD
Pirenzepine—CHRM5—Regulation of Actin Cytoskeleton—MAPK3—atherosclerosis	0.00177	0.00222	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—CX3CR1—atherosclerosis	0.00177	0.00222	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—CASR—atherosclerosis	0.00177	0.00222	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—CCR2—atherosclerosis	0.00175	0.0022	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—EDNRA—atherosclerosis	0.00175	0.0022	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—CX3CL1—atherosclerosis	0.00173	0.00217	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—atherosclerosis	0.00172	0.00216	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—GHRL—atherosclerosis	0.00171	0.00214	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—HRH1—atherosclerosis	0.00169	0.00212	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—PPARG—atherosclerosis	0.00168	0.0021	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.00166	0.00208	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.00165	0.00206	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—CNR2—atherosclerosis	0.00164	0.00206	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.00161	0.00202	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—SERPINE1—atherosclerosis	0.00151	0.00189	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—KNG1—atherosclerosis	0.0015	0.00188	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—AGTR1—atherosclerosis	0.00149	0.00187	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—AGT—atherosclerosis	0.00149	0.00187	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—CCL4—atherosclerosis	0.00146	0.00183	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—UTS2—atherosclerosis	0.00143	0.00179	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—CCL3—atherosclerosis	0.00141	0.00177	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—CCR2—atherosclerosis	0.00141	0.00176	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—EDNRA—atherosclerosis	0.00141	0.00176	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.00138	0.00173	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—F2—atherosclerosis	0.00138	0.00173	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—GHRL—atherosclerosis	0.00137	0.00172	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—CASR—atherosclerosis	0.00137	0.00172	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—APOA4—atherosclerosis	0.00133	0.00166	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.00132	0.00166	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—UTS2—atherosclerosis	0.0013	0.00163	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—CCR2—atherosclerosis	0.00128	0.0016	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—EDNRA—atherosclerosis	0.00128	0.0016	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—CNR2—atherosclerosis	0.00128	0.0016	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.00127	0.0016	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.00127	0.0016	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—EDN1—atherosclerosis	0.00126	0.00158	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—CCL5—atherosclerosis	0.00126	0.00157	CbGpPWpGaD
Pirenzepine—CHRM1—Regulation of Actin Cytoskeleton—MAPK3—atherosclerosis	0.00125	0.00156	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—GHRL—atherosclerosis	0.00125	0.00156	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—CX3CR1—atherosclerosis	0.00125	0.00156	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—CASR—atherosclerosis	0.00125	0.00156	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—CCL2—atherosclerosis	0.00123	0.00154	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CCL4—atherosclerosis	0.00122	0.00153	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—CX3CL1—atherosclerosis	0.00122	0.00153	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—KNG1—atherosclerosis	0.0012	0.00151	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—AGTR1—atherosclerosis	0.0012	0.0015	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—HRH1—atherosclerosis	0.00119	0.00149	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—CNR2—atherosclerosis	0.00116	0.00145	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—APOA2—atherosclerosis	0.00114	0.00143	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.00114	0.00142	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—MAPK8—atherosclerosis	0.00113	0.00141	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—KNG1—atherosclerosis	0.00109	0.00137	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—UTS2—atherosclerosis	0.00109	0.00137	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—AGTR1—atherosclerosis	0.00109	0.00136	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—AGT—atherosclerosis	0.00105	0.00132	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CX3CR1—atherosclerosis	0.00104	0.00131	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CASR—atherosclerosis	0.00104	0.00131	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CX3CL1—atherosclerosis	0.00102	0.00128	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—EDN1—atherosclerosis	0.00102	0.00127	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—CCL5—atherosclerosis	0.00101	0.00126	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—CCL3—atherosclerosis	0.000996	0.00125	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—CCR2—atherosclerosis	0.000992	0.00124	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—EDNRA—atherosclerosis	0.000992	0.00124	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CNR2—atherosclerosis	0.000971	0.00122	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—CXCL8—atherosclerosis	0.000971	0.00122	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—F2—atherosclerosis	0.00097	0.00122	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—MMP3—atherosclerosis	0.000969	0.00121	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000967	0.00121	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—GHRL—atherosclerosis	0.000966	0.00121	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—PRKCG—atherosclerosis	0.000958	0.0012	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—APOA4—atherosclerosis	0.000934	0.00117	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000931	0.00117	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—EDN1—atherosclerosis	0.000922	0.00115	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—CCL5—atherosclerosis	0.000915	0.00115	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—EDNRA—atherosclerosis	0.0009	0.00113	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—CCR2—atherosclerosis	0.0009	0.00113	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000898	0.00112	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—GHRL—atherosclerosis	0.000877	0.0011	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—PRKCG—atherosclerosis	0.00087	0.00109	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—VWF—atherosclerosis	0.000866	0.00108	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—CCL2—atherosclerosis	0.000865	0.00108	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CCL4—atherosclerosis	0.000861	0.00108	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—APOC3—atherosclerosis	0.00086	0.00108	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—LDLR—atherosclerosis	0.000855	0.00107	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—KNG1—atherosclerosis	0.000848	0.00106	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000843	0.00106	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—AGT—atherosclerosis	0.000843	0.00106	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CCL3—atherosclerosis	0.000835	0.00105	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—APOA2—atherosclerosis	0.000804	0.00101	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—NCF1—atherosclerosis	0.0008	0.001	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—F2—atherosclerosis	0.000779	0.000975	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—KNG1—atherosclerosis	0.00077	0.000965	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—UTS2—atherosclerosis	0.000767	0.000961	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—AGTR1—atherosclerosis	0.000766	0.000959	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—AGT—atherosclerosis	0.000765	0.000959	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—EDNRA—atherosclerosis	0.000755	0.000946	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CCR2—atherosclerosis	0.000755	0.000946	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CYBA—atherosclerosis	0.000752	0.000942	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000745	0.000933	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—GHRL—atherosclerosis	0.000736	0.000922	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PLAT—atherosclerosis	0.000736	0.000922	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PARP1—atherosclerosis	0.000736	0.000922	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CX3CR1—atherosclerosis	0.000736	0.000922	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CASR—atherosclerosis	0.000736	0.000922	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CX3CL1—atherosclerosis	0.000722	0.000904	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—IL6—atherosclerosis	0.000719	0.0009	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—EDN1—atherosclerosis	0.000715	0.000895	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—CCL5—atherosclerosis	0.000709	0.000888	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—F2—atherosclerosis	0.000707	0.000886	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CNR2—atherosclerosis	0.000684	0.000857	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—CXCL8—atherosclerosis	0.000684	0.000856	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—MMP3—atherosclerosis	0.000682	0.000855	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000681	0.000853	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—PIK3CG—atherosclerosis	0.000677	0.000848	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000674	0.000845	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—EDN1—atherosclerosis	0.000649	0.000813	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—KNG1—atherosclerosis	0.000646	0.000809	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—CCL5—atherosclerosis	0.000644	0.000807	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—AGTR1—atherosclerosis	0.000642	0.000805	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—CCL2—atherosclerosis	0.00063	0.000789	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PLG—atherosclerosis	0.000626	0.000784	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—PRKCG—atherosclerosis	0.000612	0.000767	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—VWF—atherosclerosis	0.00061	0.000764	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—APOC3—atherosclerosis	0.000606	0.000759	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—LDLR—atherosclerosis	0.000602	0.000754	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—AGT—atherosclerosis	0.000593	0.000743	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—SOCS3—atherosclerosis	0.000593	0.000743	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CCL3—atherosclerosis	0.000588	0.000737	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—MMP3—atherosclerosis	0.000573	0.000717	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—IGF2—atherosclerosis	0.00057	0.000714	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—NCF1—atherosclerosis	0.000563	0.000706	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—APOB—atherosclerosis	0.000553	0.000693	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—CXCL8—atherosclerosis	0.000549	0.000687	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—F2—atherosclerosis	0.000548	0.000687	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—EDN1—atherosclerosis	0.000545	0.000682	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CCL5—atherosclerosis	0.00054	0.000677	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—AGT—atherosclerosis	0.000539	0.000675	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CCR2—atherosclerosis	0.000532	0.000666	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—EDNRA—atherosclerosis	0.000532	0.000666	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CYBA—atherosclerosis	0.00053	0.000663	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—LPL—atherosclerosis	0.000528	0.000662	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000525	0.000657	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PARP1—atherosclerosis	0.000518	0.000649	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PLAT—atherosclerosis	0.000518	0.000649	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—GHRL—atherosclerosis	0.000518	0.000649	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PRKCG—atherosclerosis	0.000514	0.000644	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—SPP1—atherosclerosis	0.0005	0.000627	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—CXCL8—atherosclerosis	0.000498	0.000624	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—F2—atherosclerosis	0.000498	0.000624	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000476	0.000597	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PDGFB—atherosclerosis	0.000463	0.00058	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—KNG1—atherosclerosis	0.000455	0.00057	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	0.000452	0.000567	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—AGT—atherosclerosis	0.000452	0.000566	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	0.000444	0.000556	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—APOE—atherosclerosis	0.000443	0.000555	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—LEP—atherosclerosis	0.000443	0.000555	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PLG—atherosclerosis	0.000441	0.000552	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CAV1—atherosclerosis	0.000439	0.00055	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—APOA1—atherosclerosis	0.000438	0.000548	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ESR1—atherosclerosis	0.000423	0.00053	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—F2—atherosclerosis	0.000418	0.000523	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	0.000417	0.000523	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—MMP3—atherosclerosis	0.000403	0.000505	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—IGF2—atherosclerosis	0.000401	0.000503	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PIK3CG—atherosclerosis	0.0004	0.000501	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—APOB—atherosclerosis	0.00039	0.000488	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000386	0.000484	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—EDN1—atherosclerosis	0.000383	0.00048	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—MAPK3—atherosclerosis	0.000383	0.00048	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CCL5—atherosclerosis	0.00038	0.000477	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—INS—atherosclerosis	0.000378	0.000474	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CCL2—atherosclerosis	0.000372	0.000466	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—LPL—atherosclerosis	0.000372	0.000466	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—IGF1—atherosclerosis	0.000366	0.000458	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	0.000362	0.000453	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—SPP1—atherosclerosis	0.000352	0.000441	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	0.000351	0.000439	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—SERPINE1—atherosclerosis	0.000348	0.000435	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—NOS3—atherosclerosis	0.000332	0.000416	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	0.000326	0.000408	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—AGT—atherosclerosis	0.000318	0.000399	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—LEP—atherosclerosis	0.000312	0.000391	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—APOE—atherosclerosis	0.000312	0.000391	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CAV1—atherosclerosis	0.000309	0.000387	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—APOA1—atherosclerosis	0.000308	0.000386	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ESR1—atherosclerosis	0.000298	0.000373	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CXCL8—atherosclerosis	0.000294	0.000369	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—F2—atherosclerosis	0.000294	0.000368	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—AKT1—atherosclerosis	0.000284	0.000356	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	0.000281	0.000353	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—IL6—atherosclerosis	0.00028	0.000351	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	0.00027	0.000338	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—INS—atherosclerosis	0.000266	0.000334	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—MMP9—atherosclerosis	0.000266	0.000333	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—NFKB1—atherosclerosis	0.000263	0.00033	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CCL2—atherosclerosis	0.000262	0.000328	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—MAPK8—atherosclerosis	0.000259	0.000324	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—AKT1—atherosclerosis	0.000258	0.000323	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—IGF1—atherosclerosis	0.000258	0.000323	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	0.000245	0.000307	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—VEGFA—atherosclerosis	0.000239	0.000299	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—STAT3—atherosclerosis	0.000237	0.000297	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—NOS3—atherosclerosis	0.000234	0.000293	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—MAPK3—atherosclerosis	0.000226	0.000283	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—TGFB1—atherosclerosis	0.000219	0.000275	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	0.000207	0.00026	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	0.0002	0.000251	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—IL6—atherosclerosis	0.000197	0.000247	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—MMP9—atherosclerosis	0.000187	0.000235	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	0.000185	0.000232	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	0.000182	0.000228	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	0.000182	0.000228	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	0.000168	0.000211	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—STAT3—atherosclerosis	0.000167	0.000209	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—IL6—atherosclerosis	0.000165	0.000207	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	0.000159	0.000199	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	0.000154	0.000194	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—AKT1—atherosclerosis	0.000153	0.000191	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—IL6—atherosclerosis	0.000116	0.000146	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—AKT1—atherosclerosis	0.000107	0.000135	CbGpPWpGaD
